GSK plc GSK announced that its therapeutic herpes simplex virus (HSV) vaccine candidate, GSK3943104, did not meet the primary endpoint in the combined phase I/II proof-of-concept study.

THE herpes simplex virus type 1 is best known as the villain behind the dreaded cold sore. When it’s not triggering eruptions ...

A safe and effective vaccine for primary prevention of HSV infection would be useful to control transmission, and several vaccines are currently in development and undergoing evaluation.

GSK has stopped (PDF) development of one of the lead programs from its $2.1 billi | GSK has stopped development of one of the lead programs from its $2.1 billion Affinivax takeover, axing a phase 2 ...

Penn has designed mRNA vaccines to prevent Lyme disease, norovirus, and herpes simplex virus 2. Penn is also studying how mRNA can treat sickle cell disease, deadly food allergies, and even cancer ...

Dr. Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. Herpes simplex virus (HSV) is a common—and one ...

Penn is also looking at designing mRNA vaccines for Lyme disease, norovirus, herpes simplex virus 2, sickle cell disease, deadly food allergies and cancer.

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

COVID and flu season is coming sooner than you might think, and getting up to date with vaccines is the best way to protect yourself in the months ahead. This year’s COVID vaccine is a little ...

Herpes simplex virus type 1 (HSV-1), the cause of the common cold sore, can spread into the central nervous system and preferences for certain parts of the brain. Study results published today in ...

Some weeks Laja is doing outreach, spending her day educating a community about which vaccines she can provide and what diseases they prevent. “It’s my responsibility to tell the mothers to ...